Lux Capital was founded in 2000 by Josh Wolfe, Peter Hébert, and Robert Paull, and has spent more than two decades funding science- and engineering-heavy companies long before they look mainstream. What distinguishes the firm is its refusal to separate venture investing from frontier technical ambition: Lux's own materials treat hard science, difficult regulation, and long commercialization arcs as the price of the category rather than reasons to pass. That patience produced Auris Health, the surgical robotics company Johnson & Johnson acquired for up to $6.1 billion in 2019, seven years after Lux first invested, alongside early positions in Anduril, Recursion, and Hugging Face.
Auris Health's 2019 acquisition by Johnson & Johnson for up to $6.1 billion - Lux first invested in the surgical robotics company in 2012, seven years before the deal